Eyebright Income Tax Expense vs Tax Provision Analysis

688050 Stock

89.09 0.66 0.74%

Eyebright Medical financial indicator trend analysis is much more than just examining Eyebright Medical latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Eyebright Medical is a good investment. Please check the relationship between Eyebright Medical Income Tax Expense and its Tax Provision accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Eyebright Medical Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Income Tax Expense vs Tax Provision

Income Tax Expense vs Tax Provision Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Eyebright Medical Income Tax Expense account and Tax Provision. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Eyebright Medical's Income Tax Expense and Tax Provision is 0.95. Overlapping area represents the amount of variation of Income Tax Expense that can explain the historical movement of Tax Provision in the same time period over historical financial statements of Eyebright Medical Technology, assuming nothing else is changed. The correlation between historical values of Eyebright Medical's Income Tax Expense and Tax Provision is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Income Tax Expense of Eyebright Medical Technology are associated (or correlated) with its Tax Provision. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Tax Provision has no effect on the direction of Income Tax Expense i.e., Eyebright Medical's Income Tax Expense and Tax Provision go up and down completely randomly.

Correlation Coefficient

0.95

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Income Tax Expense

Tax Provision

The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.

Most indicators from Eyebright Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Eyebright Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Eyebright Medical Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Selling General Administrative is expected to grow to about 226.9 M, whereas Tax Provision is forecasted to decline to about 25.8 M.

	2021	2022	2023	2024 (projected)
Interest Expense	736.9K	2.0M	9.8M	10.3M
Depreciation And Amortization	42.0M	58.7M	67.5M	70.9M

Interest Expense Depreciation And Amortization

Eyebright Medical fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Short Term Investments	Net Receivables	Net Invested Capital
Total Assets		0.96	0.32	0.93	0.91	0.96	-0.61	0.96	0.87	0.86	0.97	0.74	0.99	0.84	0.92	0.94	0.25	0.88	0.93	0.87	-0.35	0.96	0.91	0.34	0.8	0.96
Short Long Term Debt Total	0.96		0.46	0.86	0.92	0.88	-0.69	0.89	0.76	0.89	0.89	0.75	0.95	0.77	0.85	0.82	0.37	0.9	0.86	0.9	-0.31	0.88	0.89	0.37	0.72	0.96
Other Current Liab	0.32	0.46		0.0	0.56	0.11	-0.58	0.14	-0.15	0.53	0.12	0.59	0.32	0.11	0.1	-0.02	0.57	0.59	0.05	0.65	-0.2	0.08	0.5	0.61	-0.05	0.44
Total Current Liabilities	0.93	0.86	0.0		0.74	0.99	-0.35	0.98	0.98	0.68	0.99	0.58	0.92	0.85	0.98	0.97	0.01	0.68	1.0	0.65	-0.28	0.98	0.74	0.17	0.86	0.87
Total Stockholder Equity	0.91	0.92	0.56	0.74		0.8	-0.74	0.8	0.64	0.96	0.81	0.82	0.9	0.84	0.74	0.76	0.43	0.99	0.74	0.97	-0.35	0.81	0.99	0.45	0.74	0.96
Property Plant And Equipment Net	0.96	0.88	0.11	0.99	0.8		-0.4	1.0	0.96	0.72	1.0	0.66	0.95	0.85	0.98	0.97	0.04	0.74	0.99	0.71	-0.31	0.99	0.79	0.26	0.86	0.9
Net Debt	-0.61	-0.69	-0.58	-0.35	-0.74	-0.4		-0.39	-0.23	-0.87	-0.41	-0.43	-0.6	-0.4	-0.28	-0.43	-0.74	-0.8	-0.32	-0.86	0.38	-0.48	-0.78	-0.13	-0.26	-0.62
Retained Earnings	0.96	0.89	0.14	0.98	0.8	1.0	-0.39		0.96	0.72	1.0	0.72	0.96	0.85	0.98	0.96	0.0	0.75	0.99	0.71	-0.33	0.98	0.79	0.34	0.86	0.91
Accounts Payable	0.87	0.76	-0.15	0.98	0.64	0.96	-0.23	0.96		0.57	0.96	0.53	0.86	0.82	0.95	0.96	-0.14	0.58	0.97	0.53	-0.27	0.95	0.64	0.14	0.87	0.79
Cash	0.86	0.89	0.53	0.68	0.96	0.72	-0.87	0.72	0.57		0.73	0.66	0.84	0.78	0.65	0.71	0.56	0.97	0.67	0.97	-0.4	0.77	0.97	0.25	0.66	0.91
Non Current Assets Total	0.97	0.89	0.12	0.99	0.81	1.0	-0.41	1.0	0.96	0.73		0.68	0.96	0.85	0.98	0.97	0.04	0.75	0.99	0.72	-0.32	0.99	0.8	0.29	0.85	0.91
Non Currrent Assets Other	0.74	0.75	0.59	0.58	0.82	0.66	-0.43	0.72	0.53	0.66	0.68		0.81	0.64	0.64	0.59	0.02	0.78	0.61	0.76	-0.3	0.63	0.76	0.86	0.62	0.81
Cash And Short Term Investments	0.99	0.95	0.32	0.92	0.9	0.95	-0.6	0.96	0.86	0.84	0.96	0.81		0.82	0.9	0.93	0.16	0.87	0.91	0.85	-0.38	0.95	0.89	0.44	0.8	0.96
Common Stock Shares Outstanding	0.84	0.77	0.11	0.85	0.84	0.85	-0.4	0.85	0.82	0.78	0.85	0.64	0.82		0.83	0.84	0.09	0.8	0.84	0.71	-0.32	0.85	0.84	0.2	0.97	0.89
Non Current Liabilities Total	0.92	0.85	0.1	0.98	0.74	0.98	-0.28	0.98	0.95	0.65	0.98	0.64	0.9	0.83		0.93	-0.02	0.68	0.99	0.64	-0.28	0.95	0.72	0.27	0.84	0.87
Inventory	0.94	0.82	-0.02	0.97	0.76	0.97	-0.43	0.96	0.96	0.71	0.97	0.59	0.93	0.84	0.93		0.02	0.72	0.95	0.68	-0.29	0.99	0.78	0.17	0.85	0.84
Other Current Assets	0.25	0.37	0.57	0.01	0.43	0.04	-0.74	0.0	-0.14	0.56	0.04	0.02	0.16	0.09	-0.02	0.02		0.51	0.0	0.6	-0.03	0.08	0.48	-0.17	-0.1	0.29
Other Stockholder Equity	0.88	0.9	0.59	0.68	0.99	0.74	-0.8	0.75	0.58	0.97	0.75	0.78	0.87	0.8	0.68	0.72	0.51		0.69	0.99	-0.34	0.76	0.99	0.41	0.69	0.93
Total Liab	0.93	0.86	0.05	1.0	0.74	0.99	-0.32	0.99	0.97	0.67	0.99	0.61	0.91	0.84	0.99	0.95	0.0	0.69		0.65	-0.28	0.97	0.73	0.22	0.86	0.87
Total Current Assets	0.87	0.9	0.65	0.65	0.97	0.71	-0.86	0.71	0.53	0.97	0.72	0.76	0.85	0.71	0.64	0.68	0.6	0.99	0.65		-0.34	0.73	0.97	0.41	0.6	0.91
Short Term Debt	-0.35	-0.31	-0.2	-0.28	-0.35	-0.31	0.38	-0.33	-0.27	-0.4	-0.32	-0.3	-0.38	-0.32	-0.28	-0.29	-0.03	-0.34	-0.28	-0.34		-0.33	-0.33	-0.15	-0.26	-0.37
Intangible Assets	0.96	0.88	0.08	0.98	0.81	0.99	-0.48	0.98	0.95	0.77	0.99	0.63	0.95	0.85	0.95	0.99	0.08	0.76	0.97	0.73	-0.33		0.81	0.21	0.84	0.89
Common Stock	0.91	0.89	0.5	0.74	0.99	0.79	-0.78	0.79	0.64	0.97	0.8	0.76	0.89	0.84	0.72	0.78	0.48	0.99	0.73	0.97	-0.33	0.81		0.37	0.74	0.94
Short Term Investments	0.34	0.37	0.61	0.17	0.45	0.26	-0.13	0.34	0.14	0.25	0.29	0.86	0.44	0.2	0.27	0.17	-0.17	0.41	0.22	0.41	-0.15	0.21	0.37		0.22	0.42
Net Receivables	0.8	0.72	-0.05	0.86	0.74	0.86	-0.26	0.86	0.87	0.66	0.85	0.62	0.8	0.97	0.84	0.85	-0.1	0.69	0.86	0.6	-0.26	0.84	0.74	0.22		0.83
Net Invested Capital	0.96	0.96	0.44	0.87	0.96	0.9	-0.62	0.91	0.79	0.91	0.91	0.81	0.96	0.89	0.87	0.84	0.29	0.93	0.87	0.91	-0.37	0.89	0.94	0.42	0.83

Click cells to compare fundamentals

Eyebright Medical Account Relationship Matchups

Eyebright Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	685.8M	1.6B	2.0B	2.2B	3.1B	3.2B
Short Long Term Debt Total	7.7M	894.5K	154.8M	162.8M	187.2M	196.6M
Other Current Liab	21.9M	74.9M	133.9M	133.9M	137.3K	130.4K
Total Current Liabilities	23.1M	77.1M	139.4M	147.7M	377.8M	396.7M
Total Stockholder Equity	617.6M	1.5B	1.7B	1.9B	2.1B	1.2B
Property Plant And Equipment Net	183.1M	267.1M	558.7M	674.2M	1.3B	1.3B
Net Debt	(195.4M)	(536.8M)	(318.0M)	(192.1M)	(172.9M)	(181.5M)
Retained Earnings	2.5M	90.0M	213.5M	391.4M	647.2M	679.5M
Accounts Payable	280.9K	2.2M	5.6M	13.9M	49.0M	51.5M
Cash	196.3M	536.8M	472.9M	354.9M	536.7M	308.0M
Non Current Assets Total	351.3M	492.4M	928.9M	1.2B	2.0B	2.1B
Non Currrent Assets Other	42.2M	87.2M	86.2M	317.6M	170.0M	107.0M
Cash And Short Term Investments	196.3M	537.1M	473.4M	836.9M	962.4M	1.0B
Common Stock Shares Outstanding	78.5M	89.4M	105.1M	105.3M	189.5M	106.7M
Liabilities And Stockholders Equity	685.8M	1.6B	2.0B	2.2B	2.6B	2.7B
Non Current Liabilities Total	15.1M	13.8M	168.0M	176.6M	328.1M	344.5M
Inventory	60.8M	59.1M	56.0M	78.8M	181.4M	190.4M
Other Current Assets	12.9M	466.6M	504.1M	11.3M	36.5M	34.6M
Other Stockholder Equity	536.2M	1.3B	1.4B	1.4B	1.6B	845.9M
Total Liab	38.3M	90.9M	307.5M	324.3M	705.9M	741.1M
Total Current Assets	334.5M	1.1B	1.1B	1.1B	1.0B	718.5M
Intangible Assets	100.6M	112.9M	127.8M	140.3M	252.2M	264.8M
Common Stock	78.8M	78.8M	105.1M	105.2M	121.0M	93.5M

Currently Active Assets on Macroaxis

C	Citigroup
GM	General Motors
F	Ford Motor
GM	General Motors
V	Visa Class A

Other Information on Investing in Eyebright Stock

Balance Sheet is a snapshot of the financial position of Eyebright Medical at a specified time, usually calculated after every quarter, six months, or one year. Eyebright Medical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Eyebright Medical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Eyebright currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Eyebright Income Tax Expense vs Tax Provision Analysis

Income Tax Expense vs Tax Provision

Income Tax Expense vs Tax Provision Correlation Analysis

Correlation Coefficient

Income Tax Expense

Tax Provision

Eyebright Medical fundamental ratios Correlations

Eyebright Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Eyebright Medical fundamental ratios Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Eyebright Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 1.0	Total Current Liabilities
Retained Earnings	+ 1.0	Property Plant And Equipment Net
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Non Current Assets Total	+ 1.0	Retained Earnings
Cash And Short Term Investments	+ 0.99	Total Assets
Property Plant And Equipment Net	+ 0.99	Total Current Liabilities

Cash	- 0.87	Net Debt
Total Current Assets	- 0.86	Net Debt
Other Stockholder Equity	- 0.8	Net Debt
Common Stock	- 0.78	Net Debt
Other Current Assets	- 0.74	Net Debt
Net Debt	- 0.74	Total Stockholder Equity